Action 4d Pharma - DDDD

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

16,36

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

16,36

Ouverture

Dernière Transaction

(O)

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

AIM Cancellation - 4d Pharma Plc

AIM 16 February 2023 NOTICE 16/02/2023 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM Pursuant to AIM Rule 41 the following...

IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM

eeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administ ...

4d Pharma PLC Cancellation of admission to trading on AIM

4d Pharma PLC 15 February 2023 4D pharma plc (in administration) Cancellation of admission to trading on AIM Leeds, UK, 15 February 2023 - 4D...

TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

4d Pharma PLC Updated Results from Renal Cell Carcinoma Cohort

4d Pharma PLC 02 February 2023 4D pharma plc (in administration) 4D pharma Announces Updated Results from the Renal Cell Carcinoma Cohort of the...

4d Pharma PLC Result of Meeting

4d Pharma PLC 16 January 2023 4D pharma Announces Result of General Meeting Leeds, UK - January 16, 2023 - 4D pharma plc (AIM: DDDD) (in...

4D Pharma seeks approval for equity fundraise to lift suspension

4D Pharma PLC on Friday said it was seeking shareholder approval for a USD15.0 million cash raise, as it works to lif ...

4d Pharma PLC Update on Administration and Suspension of Trading

4d Pharma PLC 30 December 2022 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON...

4D Pharma says trial results show Blautix eases IBS symptoms

4D Pharma PLC said on Wednesday that its Blautix phase 2 clinical trial results showed the treatment had a positive e ...

4d Pharma PLC Blautix Phase II Clinical Trial Results Published

4d Pharma PLC 16 November 2022 4D pharma's Blautix(R) Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

DDDD - Frequently Asked Questions (FAQ)

What is the current 4d Pharma share price?

The current share price of 4d Pharma is 16,36p

What is the 1 year trading range for 4d Pharma share price?

4d Pharma has traded in the range of 0,00p to 0,00p during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
GCMGcm Resources Plc	2,50p (36,99%)	19,2M
CRTCare Reit Plc	108,60p (33,58%)	85,61M
DELTDeltic Energy Plc	3,875p (19,23%)	3,08M
SOLISolid State Plc	202,50p (15,71%)	463,14k
PHEPowerhouse Energy Group Plc	0,75p (15,38%)	36,4M
SNGSynairgen Plc	1,20p (-39,85%)	6,45M
HEMOHemogenyx Pharmaceuticals Plc	195,00p (-36,17%)	712,91k
THRUThruvision Group Plc	1,60p (-28,89%)	425,77k
HVTHeavitree Brewery Plc	200,00p (-27,27%)	9,43k
ADFFacilities By Adf Plc	20,50p (-26,79%)	3,62M
VELAVela Technologies Plc	0,003p (7,14%)	2,23B
PREMPremier African Minerals Limited	0,0107p (-13,71%)	1,4B
UKOGUk Oil & Gas Plc	0,01p (-9,09%)	363,68M
CORCorpus Resources Plc	0,015p (3,45%)	304,93M
LLOYLloyds Banking Group Plc	67,16p (-2,92%)	197,24M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

4d Pharma Plc (DDDD)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés